7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Bristol-Myers Squibb Company
(NYSE:BMY) 

BMY stock logo

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. The company offers products in hematology, oncology, cardiovascular, and immunology therapeutic classes. Its products include Revlimid, an oral immunomodulatory drug for the tr...

Founded: 1887
Full Time Employees: 30,000
Sector: Healthcare
Industry: Drug Manufacturers-General

Share this website to your friends
Bristol-Myers Squibb Number of Twitter Followers
202204 202206 202207 202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 022.5245.0367.5590.07112.58135.1157.62Thousand
Bristol-Myers Squibb Days Payable Outstanding ttm (DPO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 016.2832.5548.8365.1181.3897.66113.94
Bristol-Myers Squibb Days Receivable Outstanding ttm (DSO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 018.1636.3154.4772.6390.78108.94127.1
Bristol-Myers Squibb Days Inventory Outstanding ttm (DIO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 013.2826.5539.8353.166.3879.6592.93
Bristol-Myers Squibb Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 012344.995.996.99
Bristol-Myers Squibb Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.931.852.783.714.635.566.49
Bristol-Myers Squibb Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.871.732.63.464.335.196.06
Bristol-Myers Squibb P/S ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.352.714.065.416.778.129.47
Bristol-Myers Squibb (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 08.4916.9725.4633.9542.4350.9259.41
Bristol-Myers Squibb P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.953.95.857.89.7511.713.65
No extra charts and metrics for this ticker.